BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1124 related articles for article (PubMed ID: 33945642)

  • 1. Lymphopenia and lung complications in patients with coronavirus disease-2019 (COVID-19): A retrospective study based on clinical data.
    Zaboli E; Majidi H; Alizadeh-Navaei R; Hedayatizadeh-Omran A; Asgarian-Omran H; Vahedi Larijani L; Khodaverdi V; Amjadi O
    J Med Virol; 2021 Sep; 93(9):5425-5431. PubMed ID: 33945642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
    Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
    Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus.
    Cheng Y; Yue L; Wang Z; Zhang J; Xiang G
    J Diabetes Complications; 2021 Feb; 35(2):107809. PubMed ID: 33288414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased in-hospital mortality associated with aspirin administration in hospitalized patients due to severe COVID-19.
    Haji Aghajani M; Moradi O; Amini H; Azhdari Tehrani H; Pourheidar E; Rabiei MM; Sistanizad M
    J Med Virol; 2021 Sep; 93(9):5390-5395. PubMed ID: 33913549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study.
    Mousavi SA; Rad S; Rostami T; Rostami M; Mousavi SA; Mirhoseini SA; Kiumarsi A
    Hematology; 2020 Dec; 25(1):383-388. PubMed ID: 33124971
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness.
    Rokni M; Ahmadikia K; Asghari S; Mashaei S; Hassanali F
    BMC Infect Dis; 2020 Nov; 20(1):869. PubMed ID: 33225909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.
    Urra JM; Cabrera CM; Porras L; Ródenas I
    Clin Immunol; 2020 Aug; 217():108486. PubMed ID: 32479985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and demographic characteristics of patients with COVID-19 infection: Statistics from a single hospital in Iran.
    Samsami M; Mehravaran E; Tabarsi P; Javadi A; Arsang-Jang S; Komaki A; Taheri M; Ghafouri-Fard S
    Hum Antibodies; 2021; 29(1):49-54. PubMed ID: 32986663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients.
    Zhang JJ; Cao YY; Tan G; Dong X; Wang BC; Lin J; Yan YQ; Liu GH; Akdis M; Akdis CA; Gao YD
    Allergy; 2021 Feb; 76(2):533-550. PubMed ID: 32662525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of clinical parameters in predicting the severity of COVID-19.
    Shang W; Dong J; Ren Y; Tian M; Li W; Hu J; Li Y
    J Med Virol; 2020 Oct; 92(10):2188-2192. PubMed ID: 32436996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parenchymal lung changes on CT in patients with coronavirus disease 2019 (COVID-19)].
    Halldorsson AB; Axelsson GT; Jonsson HM; Isaksson JD; Hardardottir H; Gudmundsson G; Hansdottir S
    Laeknabladid; 2021 Oct; 107(10):460-468. PubMed ID: 34585672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics, laboratory abnormalities and CT findings of COVID-19 patients and risk factors of severe disease: a systematic review and meta-analysis.
    Xie J; Wang Q; Xu Y; Zhang T; Chen L; Zuo X; Liu J; Huang L; Zhan P; Lv T; Song Y
    Ann Palliat Med; 2021 Feb; 10(2):1928-1949. PubMed ID: 33548996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of clinical features and imaging signs of COVID-19 with the assistance of artificial intelligence.
    Ren HW; Wu Y; Dong JH; An WM; Yan T; Liu Y; Liu CC
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8210-8218. PubMed ID: 32767351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA.
    Gayam V; Konala VM; Naramala S; Garlapati PR; Merghani MA; Regmi N; Balla M; Adapa S
    J Med Virol; 2020 Oct; 92(10):2181-2187. PubMed ID: 32449972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis.
    Tabata S; Imai K; Kawano S; Ikeda M; Kodama T; Miyoshi K; Obinata H; Mimura S; Kodera T; Kitagaki M; Sato M; Suzuki S; Ito T; Uwabe Y; Tamura K
    Lancet Infect Dis; 2020 Sep; 20(9):1043-1050. PubMed ID: 32539988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory findings of COVID-19: a systematic review and meta-analysis.
    Zhang ZL; Hou YL; Li DT; Li FZ
    Scand J Clin Lab Invest; 2020 Oct; 80(6):441-447. PubMed ID: 32449374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphopenia predicted illness severity and recovery in patients with COVID-19: A single-center, retrospective study.
    Liu J; Li H; Luo M; Liu J; Wu L; Lin X; Li R; Wang Z; Zhong H; Zheng W; Zhou Y; Jiang D; Tan X; Zhou Z; Peng H; Zhang G
    PLoS One; 2020; 15(11):e0241659. PubMed ID: 33206680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal changes of haematological and radiological findings of the COVID-19 infection-a review of literature.
    Lim AYH; Goh JL; Chua MCW; Heng BH; Abisheganaden JA; George PP
    BMC Pulm Med; 2021 Jan; 21(1):37. PubMed ID: 33482780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of peripheral blood differential counts in hospitalized patients with COVID-19.
    Pakos IS; Lo KB; Salacup G; Pelayo J; Bhargav R; Peterson E; Gul F; DeJoy R; Albano J; Patarroyo-Aponte G; Rangaswami J; Azmaiparashvili Z
    Eur J Haematol; 2020 Dec; 105(6):773-778. PubMed ID: 32794205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of chest CT quantitative pulmonary inflammatory index in the evaluation of the course and treatment outcome of COVID-19 pneumonia.
    Peng S; Chen J; Zhang W; Zhang B; Liu Z; Liu L; Wu Z; Fu R; Li X; Lv F
    Sci Rep; 2021 Apr; 11(1):7752. PubMed ID: 33833340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.